The accuracy of a point of care equipment, HemoCue Glucose 201 RT, for dysglycaemia screening in patients with coronary artery disease: Results from EUROASPIRE
Association between C-reactive protein and all-cause mortality and cardiovascular events in the Russian Federation. Preliminary results from ESSE-RF study